Replimune Group, Inc. — Director's Dealing 2019

Nov 9, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Replimune Group, Inc. (REPL)
CIK: 0001737953
Period of Report: 2019-11-06

Reporting Person: Love Colin (Chief Operating Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-11-06	Common Stock	S	11250	$17.02	Disposed	1062774	Direct
2019-11-06	Common Stock	S	11250	$17.00	Disposed	1051524	Direct

Footnotes

F1: The sales reported on this Form 4 were made by the reporting person pursuant to a trading plan adopted on March 7, 2019 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended.

F2: Following the sales reported on this Form 4, the reporting person continues to beneficially own 1,051,524 shares of the Issuer's common stock. The reporting person also holds options to acquire 328,103 shares of the Issuer's common stock, 115,169 of which are exercisable as of the date hereof.